Literature DB >> 27176569

Long noncoding RNA ANRIL: a potential novel prognostic marker in cancer: a meta-analysis.

Fang-Teng Liu1, Pei-Qian Zhu, Hong-Liang Luo, Yi Zhang, Teng-Fei Hao, Guang-Fei Xia, Zheng-Ming Zhu, Cheng Qiu.   

Abstract

INTRODUCTION: Numerous researches have showed that the dysregulation of lncRNA ANRIL play a significant role in cancer progression, and high expression of ANRIL may have important clinical value. This meta-analysis aims to investigate potential clinical application role of ANRIL as a biomarker for cancer prognosis. EVIDENCE ACQUISTION: The electronic search was conducted in Pubmed, EMBASE, Web of Science, CNKI and Wanfang database (up to January 27, 2016). We collected relevant articles to explore the association between the expression levels of ANRIL and overall survival (OS). EVIDENCE SYNTHESIS: A total of 519 cancer patients from six studies were finally included. The results showed that cancer patients with high ANRIL expression may have a poorer OS (HR=1.95, 95%CI:1.37-2.53, P=0.000, fixed-effect model) than those with low ANRIL expression.
CONCLUSIONS: High expression of ANRIL is associated with poor clinical outcome. ANRIL might be act as a novel potential prognostic biomarker in various cancers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27176569

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  7 in total

1.  Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.

Authors:  Deyao Shi; Fashuai Wu; Feng Gao; Xiangcheng Qing; Zengwu Shao
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 2.  Long non-coding RNAs: a rising biotarget in colorectal cancer.

Authors:  Jian Luo; Jian Qu; Dong-Kai Wu; Zhi-Li Lu; Yue-Sheng Sun; Qiang Qu
Journal:  Oncotarget       Date:  2017-03-28

Review 3.  Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.

Authors:  Chao Yang; Zhuo Li; Yajun Li; Rui Xu; Yongfeng Wang; Yu Tian; Wei Chen
Journal:  Oncotarget       Date:  2017-01-10

4.  Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.

Authors:  Federica Conte; Giulia Fiscon; Matteo Chiara; Teresa Colombo; Lorenzo Farina; Paola Paci
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

Review 5.  The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer.

Authors:  Daniela D'Arcangelo; Lavinia Tinaburri; Elena Dellambra
Journal:  Int J Mol Sci       Date:  2017-07-22       Impact factor: 5.923

6.  Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma.

Authors:  Adam M Lee; Asmaa Ferdjallah; Elise Moore; Daniel C Kim; Aritro Nath; Emily Greengard; R Stephanie Huang
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

7.  Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients.

Authors:  Ali G Alkhathami; Abdul Hadi; Mohammed Alfaifi; Mohammad Yahya Alshahrani; Amit Kumar Verma; Mirza Masroor Ali Beg
Journal:  Dis Markers       Date:  2022-01-29       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.